Antimicrobial Resistance Diagnostics Competition AMR-DxC is launched by the Division of Infection and Pathway Medicine

The Antimicrobial Resistance Diagnostics Competition is launched by the Division of Infection and Pathway Medicine at the University of Edinburgh.

Antimicrobial Resistance (AMR) is increasingly recognised as one of the greatest threats to global healthcare with substantial societal and economic impact evidenced by reports and action plans published by major national and international bodies.

There is considerable effort from academia and industry to develop better diagnostics, however so far the demand is severely under-met creating an opportunity for innovation. As a consequence, international competitions for novel diagnostics to tackle AMR were launched. These include the 1 million € EU Horizon 2020 ‘Better use of antibiotics’ prize and a $20 million prize fund set up by the National Institutes of Health (NIH) in the USA. Last year the public voted for ‘antibiotics’ as the subject of the £10 million Longitude Prize which is being organised by Nesta and part funded by Innovate UK. The goal of the Longitude Prize is to stimulate the development of novel point-of-care diagnostics to conserve antibiotics for future generations.

Motivated by this high-level response, we aim to galvanise new researchers into action by launching an annual international competition (AMR DxC) for early career scientists and students. This will stimulate innovation and synergy in scientific research and education across all disciplines (biomedical, clinical, social and beyond) and lead to the Next Generation of AMR Diagnostics.

AMR DxC starts with a bilateral UK-India competition in 2016 before going global in 2017. The objectives of AMR DxC are to connect and inspire the next generation of scientific talent as well as to spark international, interdisciplinary and innovative R&D. We will be calling for bilateral teams whose objective is to showcase work impacting the advancement of AMR diagnostics, where project work will be carried out over a three month period. The winning team will be selected by an international expert panel of leading scientists, clinicians, policy makers and industry leaders at the final AMR DxC Gathering in Edinburgh where teams will present their work.

Call for Expressions of Interest

We are now calling for Expressions of Interest for the AMR DxC competition.

AMR DxC is organised by the Division of Infection and Pathway Medicine at University of Edinburgh and supported by the Longitude Prize/Nesta and the British Society for Antimicrobial Chemotherapy (BSAC).

Story tags: 

Please tell us what you think about this website !

What do you think of the Edinburgh Infectious Diseases website?  We would be very grateful if you could spare 2 minutes to help us improve the useability and look of our pages. Thank you for your help !